Monthly Archives: October 2012

Warning and NOV Letter Summary – 3rd Quarter 2012

Each quarter Eye on FDA examines what has occurred in enforcement by the Office of Prescription Drug Promotion (OPDP), formerly known as the Division of Drug Marketing, Advertising, and Communications (DDMAC).  Apart from being instructive for those working in communications … Continue reading

Posted in Warning Letters | Comments Off

Who Ya Gonna Call?

Today Mashable carried an article entitled “Twitter’s Surprising Reaction to Meningitis Outbreak” that reported that as the meningitis outbreak associated with a contaminated steroid product unfolds, users of Twitter were more often searching for CDC than FDA. The fact that … Continue reading

Posted in Drug Safety, FDA, FDA Image | 1 Comment

Boxed Warnings and Warning Letters

Last week I reported on some of the activities during the Food and Drug Law Institute meeting on Advertising and Promotion which I attended here in Washington, where many aspects of enforcement were discussed.  I had some data I did … Continue reading

Posted in Warning Letters | Comments Off

FDLI Conference on Advertisting and Promotion

The Food and Drug Law Institute held its annual conference on Advertising and Promotion for the Pharmaceutical, Medical Device, Biologic and Veterinary Medicine Industries in Washington, D.C. on October 1 and 2.  I was able to attend sporadically and participated … Continue reading

Posted in FDA Policy, Medical Devices, New and Social Media | 1 Comment